Evidence Repository
The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • See Evidence submitted by expert panel for details.

Variant: NM_000314.6(PTEN):c.1027-1G>A

CA16042723

372482 (ClinVar)

Gene: PTEN
Condition: PTEN hamartoma tumor syndrome
Inheritance Mode: Autosomal dominant inheritance
Link to MONDO
UUID: 1efc38fb-30b6-43c9-b8d5-0f1836b4fb0e
Approved on: 2019-06-25
Published on: 2019-07-23

HGVS expressions

NM_000314.6:c.1027-1G>A
NM_000314.6(PTEN):c.1027-1G>A
NC_000010.11:g.87965286G>A
CM000672.2:g.87965286G>A
NC_000010.10:g.89725043G>A
CM000672.1:g.89725043G>A
NC_000010.9:g.89715023G>A
NG_007466.2:g.106848G>A
ENST00000700029.2:c.1120-1G>A
ENST00000710265.1:c.*56-1G>A
ENST00000688158.2:n.1762-1G>A
ENST00000688922.2:c.*857-1G>A
ENST00000700021.1:c.982-1G>A
ENST00000700022.1:c.*366-1G>A
ENST00000700023.1:n.2185-1G>A
ENST00000700024.1:n.2419-1G>A
ENST00000706954.1:c.1027-1G>A
ENST00000706955.1:c.*1062-1G>A
ENST00000686459.1:c.*613-1G>A
ENST00000688158.1:c.*1138-1G>A
ENST00000688308.1:c.1027-1G>A
ENST00000688922.1:c.948-1G>A
ENST00000693560.1:c.1546-1G>A
ENST00000371953.8:c.1027-1G>A
ENST00000371953.7:c.1027-1G>A
NM_000314.5:c.1027-1G>A
NM_001304717.2:c.1546-1G>A
NM_001304718.1:c.436-1G>A
NM_000314.7:c.1027-1G>A
NM_001304717.5:c.1546-1G>A
NM_001304718.2:c.436-1G>A
NM_000314.8:c.1027-1G>A
More

Pathogenic

Met criteria codes 3
PVS1 PM6 PM2
Not Met criteria codes 22
BA1 BP5 BP7 BP4 BP3 BP1 BP2 BS2 BS1 BS4 BS3 PP1 PP2 PP4 PM1 PM3 PM5 PM4 PS1 PS2 PS3 PS4

Evidence Links 2

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
PTEN VCEP
PTEN c.1027-1G>A (IVS8-1G>A) meets criteria to be classified as pathogenic for PTEN Hamartoma Tumor syndrome in an autosomal dominant manner using modified ACMG criteria (PMID 30311380). Please see a summary of the rules and criteria codes in the “PTEN ACMG Specifications Summary” document (assertion method column). PVS1: Null variant predicted to result in nonsense-mediated decay or causing truncation/frameshift at or 5’ to c.1121 (NM_000314.4). PM2: Absent in large sequenced populations (PMID 27535533). PM6: Assumed de novo, but without confirmation of paternity and maternity in a patient with the disease and no family history. (Internal laboratory contributor SCV000490754.2)
Met criteria codes
PVS1
I agree (FH)
PM6
1 GDx internal case. FH - I agree
PM2
absent gnomAD (I agree - FH)
Not Met criteria codes
BA1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP5
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP7
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP4
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BS2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BS1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BS4
Variant present in proband, 6yo F with thyroid nodules and macrocephaly, and her father with goiter and lipoma. Is also GDx internal family. 1 meiosis. PubMed:20962022
BS3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PP1
Variant present in proband, 6yo F with thyroid nodules and macrocephaly, and her father with goiter and lipoma. Is also GDx internal family. 1 meiosis. PubMed:20962022
PP2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PP4
Tied into PS4.
PM1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM5
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM4
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PS1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PS2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PS3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PS4
Variant present in proband, 6yo F with thyroid nodules and macrocephaly, and her father with goiter and lipoma. Is also GDx internal family. 0.5 phenotype points. PubMed:20962022
variant reported in 41yo M with "CS" - pts from CCF cohort. no other phenotype provided. PubMed:27477328
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.